Selected articles
Articles for label Vantuchová Yvetta are displayed.. Show all articles
Early diagnosis and current treatment options for basal cell carcinoma
03/2018 MUDr. Yvetta Vantuchová, Ph.D.
Basal cell carcinoma is the most common carcinoma with low malignant potential and mortality, and in early diagnosis with high curability. It occurs in different clinical forms, histological variants with different risk. Early diagnostics, based on experience, good clinical knowledge and histological variants, is a prerequisite for choosing the optimal modal treatment of both primary and recurrent treatment. Dominant surgery is the only surgical procedure in which contraindication can be done with non-surgical methods, radiation therapy, cryodestruction, photodynamic therapy or topical treatment. For advanced or metastatic basal cell carcinoma, vismodegib the first inhibitor hedgehog signaling pathway is used.
ENTIRE ARTICLE
Basal cell carcinoma is the most common carcinoma with low malignant potential and mortality, and in early diagnosis with high curability. It occurs in different clinical forms, histological variants with different risk. Early diagnostics, based on experience, good clinical knowledge and histological variants, is a prerequisite for choosing the optimal modal treatment of both primary and recurrent treatment. Dominant surgery is the only surgical procedure in which contraindication can be done with non-surgical methods, radiation therapy, cryodestruction, photodynamic therapy or topical treatment. For advanced or metastatic basal cell carcinoma, vismodegib the first inhibitor hedgehog signaling pathway is used.